A new wave of Lipitor diabetes injury lawsuits has been filed against Pfizer, Inc. over its failure to warn consumers about the risks of developing Type 2 diabetes when taking the company’s cholesterol reducing drug Lipitor (atorvastatin). Although Pfizer has said that adding a black box warning to the drug in 2012 was sufficient, lawsuits against the pharmaceutical giant allege otherwise.
Were Lipitor Warnings Too Late?
That’s what many patients who started taking the statin drug Lipitor to reduce cholesterol are alleging. Pfizer has made billions of dollars from Lipitor sales to patients who needed to decrease bad cholesterol levels, increase good cholesterol levels or who took the drug as part of a healthy lifestyle.
Many of the consumers in the latter group are healthy post-menopausal women over 46 years old who have developed Type 2 diabetes without receiving any benefit from Lipitor whatsoever. The lawsuits they have filed against Pfizer allege that they now face an increased risk of heart disease, blindness, neuropathy, kidney disease and other health problems as a result of taking the drug.
Pfizer Says MDL Not Needed
The Judicial Panel on Multidistrict Litigation is currently deciding on whether to consolidate the growing number of Lipitor diabetes lawsuits filed across the nation in multidistrict litigation (MDL) – a process that allows both sides to gather information more easily and cost effectively. However, Pfizer recently filed a motion against the MDL saying that it simply isn’t needed. Many say that the motion is simply a stalling tactic by the manufacturer to ignore the injuries being experienced by consumers of the prescription medication.
Over 20 million patients in the United States have been prescribed Lipitor. If you are a woman over 46 years old who has developed Type 2 diabetes after taking Lipitor, contact The Driscoll Firm, LLC, to discuss your situation. Our experienced product liability attorneys have recovered over $170 million against big pharmaceutical companies for clients just like you. Let us show you how we can help.
